| Code | Description | Claims | Beneficiaries | Total Paid |
| T1015 |
Clinic visit/encounter, all-inclusive |
14,065 |
12,517 |
$2.15M |
| 00003 |
Internal/system code - not a standard HCPCS code |
1,782 |
1,163 |
$320K |
| G0467 |
Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit |
80 |
62 |
$2K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
5,975 |
3,603 |
$1K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
5,609 |
3,580 |
$1K |
| 94760 |
|
17,974 |
10,439 |
$141.79 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
70 |
44 |
$111.13 |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
13 |
13 |
$43.41 |
| 97803 |
|
190 |
175 |
$25.85 |
| 92553 |
|
1,479 |
896 |
$22.04 |
| 92551 |
|
1,936 |
1,034 |
$9.90 |
| 81001 |
|
59 |
44 |
$2.74 |
| 85018 |
|
502 |
343 |
$2.05 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
10,783 |
5,933 |
$0.01 |
| H0049 |
Alcohol and/or drug screening |
11,510 |
6,326 |
$0.00 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
143 |
109 |
$0.00 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
253 |
172 |
$0.00 |
| S9451 |
Exercise classes, non-physician provider, per session |
121 |
109 |
$0.00 |
| 97802 |
|
61 |
54 |
$0.00 |
| 3074F |
|
7,837 |
4,334 |
$0.00 |
| 80053 |
Comprehensive metabolic panel |
165 |
123 |
$0.00 |
| 3080F |
|
701 |
364 |
$0.00 |
| 1036F |
|
259 |
150 |
$0.00 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
119 |
87 |
$0.00 |
| 3079F |
|
1,625 |
876 |
$0.00 |
| 3075F |
|
533 |
295 |
$0.00 |
| 3352F |
|
539 |
324 |
$0.00 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
116 |
86 |
$0.00 |
| 3044F |
|
33 |
17 |
$0.00 |
| 99441 |
|
54 |
30 |
$0.00 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
61 |
39 |
$0.00 |
| 86695 |
|
59 |
39 |
$0.00 |
| 1000F |
|
398 |
231 |
$0.00 |
| 0001F |
|
41 |
24 |
$0.00 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
26 |
14 |
$0.00 |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
78 |
52 |
$0.00 |
| 86580 |
|
15 |
15 |
$0.00 |
| 99447 |
|
67 |
48 |
$0.00 |
| G0447 |
Face-to-face behavioral counseling for obesity, 15 minutes |
13 |
13 |
$0.00 |
| 86592 |
|
61 |
36 |
$0.00 |
| 90688 |
|
19 |
13 |
$0.00 |
| 36415 |
Collection of venous blood by venipuncture |
46 |
28 |
$0.00 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
24 |
19 |
$0.00 |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
26 |
14 |
$0.00 |
| 81005 |
|
19 |
13 |
$0.00 |
| 84443 |
Thyroid stimulating hormone (TSH) |
16 |
16 |
$0.00 |
| 90686 |
|
17 |
12 |
$0.00 |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
24 |
13 |
$0.00 |
| 3078F |
|
6,305 |
3,532 |
$0.00 |
| 1033F |
|
4,927 |
2,842 |
$0.00 |
| 81002 |
|
463 |
325 |
$0.00 |
| 99449 |
|
111 |
88 |
$0.00 |
| 99173 |
|
1,932 |
1,011 |
$0.00 |
| G8431 |
Screening for depression is documented as being positive and a follow-up plan is documented |
753 |
421 |
$0.00 |
| 99215 |
Prolong outpt/office vis |
860 |
475 |
$0.00 |
| 80074 |
|
81 |
52 |
$0.00 |
| 86696 |
|
59 |
39 |
$0.00 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
132 |
76 |
$0.00 |
| 99446 |
|
32 |
18 |
$0.00 |
| 3077F |
|
694 |
369 |
$0.00 |
| 99442 |
|
12 |
12 |
$0.00 |
| 80061 |
Lipid panel |
70 |
56 |
$0.00 |
| 82274 |
|
25 |
13 |
$0.00 |
| 86703 |
|
78 |
52 |
$0.00 |
| 99448 |
|
73 |
51 |
$0.00 |
| 90473 |
|
17 |
12 |
$0.00 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
115 |
57 |
$0.00 |
| G0071 |
Payment for communication technology-based services for 5 minutes or more of a virtual (non-face-to-face) communication between an rural health clinic (rhc) or federally qualified health center (fqhc) practitioner and rhc or fqhc patient, or 5 minutes or more of remote evaluation of recorded video and/or images by an rhc or fqhc practitioner, occurring in lieu of an office visit; rhc or fqhc only |
25 |
24 |
$0.00 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
34 |
30 |
$0.00 |
| 90685 |
|
27 |
15 |
$0.00 |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
48 |
27 |
$0.00 |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
24 |
13 |
$0.00 |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
37 |
34 |
$0.00 |